HALO
HALO · Large Cap · Healthcare · Biotechnology
Free AI brief
Get the full brief on HALO
Free to track. No card required. Usually ready in 10-15 minutes.
Where HALO sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$61.23
High$128.11
Today $103.71
Stocksbrew score
71/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Lowest
$78
Current price
$103.71
Median target
$110
Highest
$130
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Forward P/E
Favorable · 34% below avg
13.15x
Price / FCF
Strong · Cash flow supports price
18.43x
ROIC
Strong · Excellent capital returns
32.1%
ROE
Favorable · 173.7% - strong capital efficiency
173.7%
Current ratio
Strong · Good liquidity position
2.71x
⚠ Things to watch
Price / sales
Rich · Overpriced by revenue
8.93x
Debt / equity
Needs attention · Unfavorable
15.18x
How it stacks up against its peers
HALO against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $14.86B | 39.1 | +41.1% | 71 |
 | $30.69B | 32.3 | +13.0% | 79 |
 | $10.48B | 20.0 | +19.7% | 79 |
 | $4.17B | 9.8 | +16.4% | 78 |
 | $1.33T | 46.6 | +45.5% | 78 |